biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a0yl-01a-21d-a10g-09
biospecimen_aliquot__bcr_aliquot_uuid	3cc80b41-603d-4735-85c7-71f540dc6e5c
biospecimen_aliquot__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099019255
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2010-11-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a10g
biospecimen_aliquot__plate_row	e
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	2.03
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a0yl-01a-21d
biospecimen_analyte__bcr_analyte_uuid	d9437ee2-5172-48a3-8250-d057907ce9ba
biospecimen_analyte__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a0yl
biospecimen_diagnostic_slides__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	69a438c7-b1e0-4990-b1e6-586c551dc79c
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a0yl
biospecimen_normal_control__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_normal_control__ncedna_dna_conc	0.137
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	146.0
biospecimen_portion__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_portion__bcr_portion_barcode	tcga-a2-a0yl-01a-21
biospecimen_portion__bcr_portion_uuid	20b2341a-38f5-4349-9b0b-57e72fa2103c
biospecimen_portion__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_portion__date_of_creation	2010-10-15
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a0yl-01a-21d
biospecimen_protocol__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_sample__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_sample__bcr_sample_uuid	905c8468-92b3-4e58-8445-6692775c7fde
biospecimen_sample__days_to_collection	205
biospecimen_sample__initial_weight	730
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a0yl.ab083371-a2ab-4f57-8fbf-0db2c91cedde.pdf
biospecimen_sample__pathology_report_uuid	ab083371-a2ab-4f57-8fbf-0db2c91cedde
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	98b333f7-f3f3-4a0c-8d5e-4eb9dbe261eb
biospecimen_shipment_portion__center_id	30
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a21v
biospecimen_shipment_portion__portion_number	41
biospecimen_shipment_portion__portion_sequence	4
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a0yl-01a-41-a21v-30
biospecimen_shipment_portion__shipment_portion_day_of_shipment	3
biospecimen_shipment_portion__shipment_portion_month_of_shipment	4
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
biospecimen_slide__bcr_sample_barcode	tcga-a2-a0yl-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a0yl-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	12b73a8a-ac2d-4cd5-b8c2-de8fd1357dea
biospecimen_slide__image_file_name	tcga-a2-a0yl-01a-02-tsb.12b73a8a-ac2d-4cd5-b8c2-de8fd1357dea.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	15
biospecimen_slide__percent_stromal_cells	35
biospecimen_slide__percent_tumor_cells	50
biospecimen_slide__percent_tumor_nuclei	60
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a0yl
biospecimen_tumor_sample__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
clinical_drug__bcr_drug_barcode	tcga-a2-a0yl-d5814
clinical_drug__bcr_drug_uuid	15d20bc4-14c3-4ec8-8005-389f518e1ac0
clinical_drug__bcr_patient_barcode	tcga-a2-a0yl
clinical_drug__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
clinical_drug__form_completion_date	2010-12-28
clinical_drug__pharma_adjuvant_cycles_count	6
clinical_drug__pharmaceutical_therapy_drug_name	cytoxan
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	154
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	50
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	940
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	5640
clinical_follow_up__bcr_followup_barcode	tcga-a2-a0yl-f59387
clinical_follow_up__bcr_followup_uuid	1dad0270-fd03-455c-9a03-28c55a7dc2b7
clinical_follow_up__bcr_patient_barcode	tcga-a2-a0yl
clinical_follow_up__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-5-12
clinical_follow_up__last_contact_days_to	1474
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	48
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n2a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_tumor_pathologic_pt	t3
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant|left upper outer quadrant|left lower inner quadrant|left lower outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-a2-a0yl
clinical_patient__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
clinical_patient__birth_days_to	-17702
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_ihc_score	3+
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	70-79%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-12-27
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	268
clinical_patient__lymph_nodes_examined_count	29
clinical_patient__lymph_nodes_examined_he_count	4
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a0yl
clinical_patient__pr_positivity_ihc_intensity_score	3+
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	90-99%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a2-a0yl
clinical_radiation__bcr_patient_uuid	b205c89f-af62-4186-acad-ed23d243fa98
clinical_radiation__bcr_radiation_barcode	tcga-a2-a0yl-r5813
clinical_radiation__bcr_radiation_uuid	45b399c8-8af8-4a9a-9507-682af704063e
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-12-28
clinical_radiation__radiation_adjuvant_fractions_total	33
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	224
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	177
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YL-01A-21D-A10G-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YL-01A-21D-A10G-09.bed.meta
manually_curated__id	tcga-a2-a0yl-01a-21d-a10g-09
manually_curated__md5sum	132c767e705eb8d92ec4775818ab7adb
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	3cc80b41-603d-4735-85c7-71f540dc6e5c
manually_curated__tumor_tag	brca
